H. Stålemark, E. Laurencikas, J. Karis, D. Gavhed, B. Fadeel et al., Incidence of Langerhans cell histiocytosis in children: a population-based study, Pediatr Blood Cancer, vol.51, issue.1, pp.76-81, 2008.

C. E. Allen, M. Merad, and K. L. Mcclain, Langerhans-cell histiocytosis, N Engl J Med, vol.379, issue.9, pp.856-868, 2018.

J. W. Keeling and J. T. Harries, Intestinal malabsorption in infants with histiocytosis X, Arch Dis Child, vol.48, issue.5, pp.350-354, 1973.

A. D. Singhi and E. A. Montgomery, Gastrointestinal tract langerhans cell histiocytosis: A clinicopathologic study of 12 patients, Am J Surg Pathol, vol.35, issue.2, pp.305-310, 2011.

S. E. Roberts, K. Thorne, and N. Thapar, A systematic review and meta analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe, J Crohns Colitis, vol.14, issue.8, pp.1119-1148, 2020.

P. Malmborg, L. Grahnquist, J. Lindholm, S. Montgomery, and H. Hildebrand, Increasing incidence of paediatric inflammatory bowel disease in northern Stockholm County, J Pediatr Gastroenterol Nutr, vol.57, issue.1, pp.29-34, 2002.

A. R. Moschen, H. Tilg, and T. Raine, IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting, Nat Rev Gastroenterol Hepatol, vol.16, issue.3, pp.185-196, 2019.

J. I. Henter, J. Karlén, U. Calming, C. Bernstrand, U. Andersson et al., Successful treatment of Langerhans'-cell histiocytosis with etanercept, N Engl J Med, vol.345, issue.21, pp.1577-1578, 2001.

G. Chohan, Y. Barnett, J. Gibson, S. Reddel, and M. H. Barnett, Langerhans cell histiocytosis with refractory central nervous system involvement responsive to infliximab, J Neurol Neurosurg Psychiatry, vol.83, issue.5, pp.573-575, 2012.

A. Flores-legarreta, O. Eckstein, T. M. Burke, and K. L. Mcclain, Anti TNF-? therapy in patients with relapsed and refractory Langerhans cell histiocytosis: a phase II study, Pediatr Hematol Oncol, vol.35, issue.5-6, pp.362-368, 2018.

E. Kvedaraite, M. Lourda, and M. Ideström, Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD, Gut, vol.65, issue.10, pp.1632-1641, 2016.

M. Lourda, S. Olsson-Åkefeldt, and D. Gavhed, Adsorptive depletion of blood monocytes reduces the levels of circulating interleukin-17A in Langerhans cell histiocytosis, Blood, vol.128, issue.9, pp.1302-1305, 2016.

H. Schlums, F. Cichocki, and B. Tesi, Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function, Immunity, vol.42, issue.3, pp.443-456, 2015.

C. S. Ma, N. Wong, and G. Rao, Monogenic mutations differentially affect the quantity and quality of T follicular helper cells in patients with human primary immunodeficiencies, J Allergy Clin Immunol, vol.136, issue.4, pp.993-1006, 2015.

C. Lee-elliott, A. J. Gould, A. Talbot, R. Snook, and J. A. , Langerhan"s cell histiocytosis complicating small bowel Crohn"s disease, Gut, vol.38, issue.2, pp.296-298, 1996.

V. R. Nanduri, K. Kelly, M. Malone, P. Milla, and J. Pritchard, Colon involvement in Langerhans' cell histiocytosis, J Pediatr Gastroenterol Nutr, vol.29, issue.4, pp.462-466, 1999.

H. Shima, T. Takahashi, and H. Shimada, Protein-losing enteropathy caused by gastrointestinal tract-involved Langerhans cell histiocytosis, Pediatrics, vol.125, issue.2, pp.426-432, 2010.

H. He, Z. Jiang, and L. Sun, A rare cause of intestinal ulcers masquerading as inflammatory bowel disease, Gastroenterology, vol.147, issue.2, pp.283-284, 2014.

J. M. Cortazar and A. S. Kim, Incidental Langerhans cell histiocytosis of the colon with BRAF p. V600E mutation, Blood, vol.130, issue.16, p.1870, 2017.

A. Therrien, Z. El-haffaf, C. Wartelle-bladou, J. Côté-daigneault, and B. N. Nguyen, Langerhans cell histiocytosis presenting as Crohn's disease: a case report, Int J Colorectal Dis, vol.33, issue.10, pp.1501-1504, 2018.

P. Powell, G. Vitug, F. Castro-silva, and A. Ray, A rare case of CD1a-negative Langerhans cell histiocytosis of the central nervous system in a child, Clin Case Rep, vol.5, issue.10, pp.1664-1667, 2017.

F. Coury, N. Annels, and A. Rivollier, Langerhans cell histiocytosis reveals a new IL-17A-dependent pathway of dendritic cell fusion, Nat Med, vol.14, issue.1, pp.81-87, 2008.

A. Morimoto, Y. Oh, and S. Nakamura, Inflammatory serum cytokines and chemokines increase associated with the disease extent in pediatric Langerhans cell histiocytosis, Cytokine, vol.97, pp.73-79, 2017.

F. Halbritter, M. Farlik, and R. Schwentner, Epigenomics and single-cell sequencing define a developmental hierarchy in langerhans cell histiocytosis, Cancer Discov, vol.9, issue.10, pp.1406-1421, 2019.

C. F. Brereton, C. E. Sutton, S. J. Lalor, E. C. Lavelle, and K. Mills, Inhibition of ERK MAPK suppresses IL-23-and IL-1-driven IL-17 production and attenuates autoimmune disease, J Immunol, vol.183, issue.3, pp.1715-1723, 2009.

G. H. Waetzig, D. Seegert, P. Rosenstiel, S. Nikolaus, and S. Schreiber, p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease, J Immunol, vol.168, issue.10, pp.5342-5351, 2002.

C. Wellbrock, M. Karasarides, and R. Marais, The RAF proteins take centre stage, Nat Rev Mol Cell Biol, vol.5, issue.11, pp.875-885, 2004.

D. Mcgovern, S. Kugathasan, and J. H. Cho, Genetics of inflammatory bowel diseases, Gastroenterology, vol.149, issue.5, pp.1163-1176, 2015.

S. Olafsson, R. E. Mcintyre, and T. Coorens, Somatic Evolution in Non-neoplastic IBD-Affected Colon, Cell, vol.182, issue.3, pp.672-684, 2020.

E. G. Serra, T. Schwerd, and L. Moutsianas, Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease, Nat Commun, vol.11, issue.1, pp.995-1015, 2020.